
Wondfo USA is a leading manufacturer and distributor of rapid point-of-care diagnostic tests, specializing in toxicology, infectious disease, women’s reproductive health, and veterinary diagnostics for North America.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Wondfo USA has recently focused on expanding its digital health offerings, launching new diagnostic apps and enhancing its rapid test portfolio to address evolving public health needs.
Launch of the WELLlife™ COVID-19/Influenza A&B rapid test with EUA approval
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Wondfo USA Co. Ltd., headquartered in Bolingbrook, Illinois, provides innovative point-of-care testing solutions for rapid diagnostics and chronic disease management. The company serves healthcare, veterinary, and clinical markets with a diverse portfolio of products. With over 15 years in operation, Wondfo USA is committed to advancing healthcare through reliable, accessible diagnostic technologies.
Bolingbrook, Illinois, USA
2009
Private company